The Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) is proud to announce it has won three awards in the 2007 "Association Trends" All-Media Contest. The annual contest is held to recognize the print, online, broadcast, electronic and audio/visual media work of associations nationwide.
AWHONN received the following:
- GOLD prize in the Informational/Promotional Piece category for the three-piece, "You Shall Find a Job!???? Fairy Godmother direct mail campaign for the Nursing Career Center. The campaign featured the Ella's story, from her graduation from nursing school through major milestones in her career. At each stage of her career, Ella's fairy godmother is on hand, advising her to visit www.NursingCareerCenter as she thought about new opportunities. The goal of the campaign was to build awareness for the Nursing Career Center as an online employment resource for nurses.
- SILVER prize in the Convention Registration Promotional Package category, for the 2007 Annual Convention Preliminary Program and collateral marketing pieces: "What Inspires You.???? The 2007 AWHONN convention theme was "Inspired to Excellence???? The campaign had a web-based interactive element in which people could submit what inspires them as a nurse and could see what other nurses had submitted to motivate and celebrate excellence among AWHONN members.
- BRONZE prize in the Catalog category, for the 2007 Resources Catalog. The AWHONN Resource Catalog underwent a major redesign in 2007, expanding the interior layout to highlight flagship products and adding more graphics and product photo displays. This attracted not only to add visual interest, but also gave customers a sense of the design, content and quality of the products in which they were interested.
AWHONN submitted only these entries and won in three of 28 categories among more than 400 entries. The list of winners appeared in the December 7, 2007 issue of Association Trends magazine.
About AWHONN
The Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) was founded in 1969 and is the foremost nursing authority that advances the health care of women and newborns through advocacy, research and the creation of high quality, evidence-based standards of care.
AWHONN's 22,000 members worldwide are clinicians, educators and executives who serve as patient care advocates focusing on the needs of women and infants. A leader in professional development, AWHONN is the first and only association to be awarded the designation Premier Provider by the American Nurses Credentialing Center for innovation and excellence in Continuing Education.
Association of Women's Health, Obstetric and Neonatal Nurses
четверг, 29 марта 2012 г.
четверг, 22 марта 2012 г.
Yeovil District Hospital Offering Women Sutureless Surgery For Vaginal Hysterectomies - England
Yeovil District Hospital is the first hospital in the South West of England to be able to offer women sutureless surgery for vaginal hysterectomies.
Thanks to the purchase of a new diathermy machine surgeons can now perform day case vaginal hysterectomies.
Consultant gynaecologist, Sharif Ismail said: "This is a new era in gynaecological surgical techniques and will reduce the operating time and the risks to the patient, reduce bleeding, the amount of pain relief which needs to be given after the operation and the post-operative stay. This not only benefits the patient but frees beds to enable the hospital to continue to reduce its waiting lists.
"Feedback from patients who participated in the trial phase was very positive and this prompted the hospital to introduce the technique to improve both health care and patient satisfaction."
Yeovil District Hospital NHS Foundation Trust provides acute care for a population of about 180,000, mostly in South Somerset, North and West Dorset, and parts of Mendip. Increasingly, however, patients are using patient choice and deciding to come to YDH from as far afield as London and Portsmouth.
Each year more than 30,000 patients are admitted as inpatients or day cases; more than 90,000 people attend outpatient appointments; around 40,000 people are treated in Accident and Emergency; and some 1,300 babies are born in the Maternity Unit. The Foundation Trust has over 7,000 members and over 1,800 staff.
Yeovil District Hospital NHS Foundation Trust
Thanks to the purchase of a new diathermy machine surgeons can now perform day case vaginal hysterectomies.
Consultant gynaecologist, Sharif Ismail said: "This is a new era in gynaecological surgical techniques and will reduce the operating time and the risks to the patient, reduce bleeding, the amount of pain relief which needs to be given after the operation and the post-operative stay. This not only benefits the patient but frees beds to enable the hospital to continue to reduce its waiting lists.
"Feedback from patients who participated in the trial phase was very positive and this prompted the hospital to introduce the technique to improve both health care and patient satisfaction."
Yeovil District Hospital NHS Foundation Trust provides acute care for a population of about 180,000, mostly in South Somerset, North and West Dorset, and parts of Mendip. Increasingly, however, patients are using patient choice and deciding to come to YDH from as far afield as London and Portsmouth.
Each year more than 30,000 patients are admitted as inpatients or day cases; more than 90,000 people attend outpatient appointments; around 40,000 people are treated in Accident and Emergency; and some 1,300 babies are born in the Maternity Unit. The Foundation Trust has over 7,000 members and over 1,800 staff.
Yeovil District Hospital NHS Foundation Trust
четверг, 15 марта 2012 г.
Mo. House Approves Amendment Allowing Pharmacies To Refuse To Stock EC, Medication Abortion Drugs
The Missouri House on Tuesday voted 115-43 to approve an amendment that would allow pharmacies to refuse to dispense emergency contraception or fill prescriptions, the Columbia Missourian reports. According to the Missourian, the bill specifically mentions the emergency contraceptive Plan B, which can prevent pregnancy if taken within 72 hours of sexual intercourse, and mifepristone, which is available by prescription only and used to induce abortion. Mifepristone is only available through a doctor and cannot be distributed by a pharmacy according to the Missourian.
The amendment, sponsored by state Rep. Ed Emery (R), prohibits lawsuits against pharmacies that do not carry the drugs and prevents the state from revoking the licenses of pharmacies that do not supply the medications. FDA recently announced that it would allow individuals ages 17 and older to purchase Plan B without a prescription (Wire, Columbia Missourian, 4/28). In addition, the amendment stipulates that pharmacies would not be required to advise people on how to obtain the medications. Current Missouri law does not address whether pharmacies must stock the drugs. According to the AP/Springfield News-Leader, Missouri's Senate already approved the original bill (S.B 296), which involves professional licensing regulations.
Many Democrats objected to Emery's amendment, arguing that the measure could hinder women's access to EC, especially for women in rural areas (Blank, AP/Springfield News-Leader, 4/28). Some Democrats also said that the amendment is an attempt to control women's bodies. "To implement a law like this, especially in a rural area, seems to me to put another road block before women," state Rep. Mary Still (D) said. According to Emery, the measure is needed to protect pharmacy owners who object to stocking EC and mifepristone (Columbia Missourian, 4/28).
Reprinted with kind permission from nationalpartnership. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2009 The Advisory Board Company. All rights reserved.
The amendment, sponsored by state Rep. Ed Emery (R), prohibits lawsuits against pharmacies that do not carry the drugs and prevents the state from revoking the licenses of pharmacies that do not supply the medications. FDA recently announced that it would allow individuals ages 17 and older to purchase Plan B without a prescription (Wire, Columbia Missourian, 4/28). In addition, the amendment stipulates that pharmacies would not be required to advise people on how to obtain the medications. Current Missouri law does not address whether pharmacies must stock the drugs. According to the AP/Springfield News-Leader, Missouri's Senate already approved the original bill (S.B 296), which involves professional licensing regulations.
Many Democrats objected to Emery's amendment, arguing that the measure could hinder women's access to EC, especially for women in rural areas (Blank, AP/Springfield News-Leader, 4/28). Some Democrats also said that the amendment is an attempt to control women's bodies. "To implement a law like this, especially in a rural area, seems to me to put another road block before women," state Rep. Mary Still (D) said. According to Emery, the measure is needed to protect pharmacy owners who object to stocking EC and mifepristone (Columbia Missourian, 4/28).
Reprinted with kind permission from nationalpartnership. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2009 The Advisory Board Company. All rights reserved.
четверг, 8 марта 2012 г.
Physical Or Sexual Violence Often Accompanies Reproductive Coercion
Young women and teenage girls often face efforts by male partners to sabotage birth control or coerce pregnancy - including damaging condoms and destroying contraceptives - and these efforts, defined as "reproductive coercion," frequently are associated with physical or sexual violence, a study by a team of researchers led by UC Davis has found.
Published online today in the January issue of the journal Contraception, the study, "Pregnancy Coercion, Intimate Partner Violence and Unintended Pregnancy," also found that among women who experienced both reproductive coercion and partner violence, the risk of unintended pregnancy doubled. The study is the first quantitative examination of the relationship between intimate partner violence, reproductive coercion and unintended pregnancy, the authors say.
"This study highlights an under-recognized phenomenon where male partners actively attempt to promote pregnancy against the will of their female partners," said lead study author Elizabeth Miller, an assistant professor of pediatrics in the UC Davis School of Medicine and a practitioner at UC Davis Children's Hospital. "Not only is reproductive coercion associated with violence from male partners, but when women report experiencing both reproductive coercion and partner violence, the risk for unintended pregnancy increases significantly."
Conducted between August 2008 and March 2009 at five reproductive health clinics in Northern California, the study involved approximately 1,300 English- and Spanish-speaking 16- to 29-year-old women who agreed to respond to a computerized survey about their experiences with relationships and pregnancy.
Study participants were asked questions about birth-control sabotage, pregnancy coercion and intimate partner violence to assess their experience of pregnancy coercion and birth control sabotage. Questions included:
"Has someone you were dating or going out with ever told you not to use any birth control" or "??¦ said he would leave you if you would not get pregnant?"
"Has someone you were dating or going out with ever taken off the condom while you were having sex so that you would get pregnant?"
Approximately one in five young women said they experienced pregnancy coercion and 15 percent said they experienced birth control sabotage. Over half the respondents - 53 percent - said they had experienced physical or sexual violence from an intimate partner. More than a third of the women who reported partner violence - 35 percent - also reported either pregnancy coercion or birth control sabotage.
"We have known about the association between partner violence and unintended pregnancy for many years," said Jay Silverman, the study's senior author and an associate professor of society, human development and health in the Harvard School of Public Health. "What this study shows is that reproductive coercion likely explains why unintended pregnancies are far more common among abused women and teens."
The study authors said the research underscores the importance of educating women seeking care about reproductive coercion, and ensuring that women who are seeking reproductive health services are offered counseling on ways to prevent pregnancy that are less vulnerable to partner interference, as well as connected to domestic violence-related services. The study also highlights the importance of working with young men to prevent both violence against female partners and coercion around pregnancy.
"This study confirms that women experiencing partner violence are more likely to have greater need for sexual and reproductive health services," Miller said. "Thus, clinical settings that offer reproductive health services likely offer the greatest opportunity to identify women experiencing partner violence and to ensure that women receive the counseling and support they may need." Comprehensive assessment in clinical settings for pregnancy coercion, birth control sabotage and intimate partner violence should be considered a priority in the context of family planning services. Moreover, public health efforts to reduce unintended pregnancy should ensure that discussions of reproductive coercion are included in pregnancy prevention programs, she said.
Other study authors include Michele Decker and Heather McCauley of the Harvard School of Public Health, Daniel Tancredi of UC Davis, Rebecca Levenson of the Family Violence Prevention Fund of San Francisco, and Jeffrey Waldman and Phyllis Schoenwald of the Planned Parenthood Shasta Diablo Affiliate.
The study was funded by the National Institute of Child Health and Human Development as well as by a UC Davis Health System Research Award and a Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Award to Miller.
Source:
Phyllis Brown
University of California - Davis - Health System
Published online today in the January issue of the journal Contraception, the study, "Pregnancy Coercion, Intimate Partner Violence and Unintended Pregnancy," also found that among women who experienced both reproductive coercion and partner violence, the risk of unintended pregnancy doubled. The study is the first quantitative examination of the relationship between intimate partner violence, reproductive coercion and unintended pregnancy, the authors say.
"This study highlights an under-recognized phenomenon where male partners actively attempt to promote pregnancy against the will of their female partners," said lead study author Elizabeth Miller, an assistant professor of pediatrics in the UC Davis School of Medicine and a practitioner at UC Davis Children's Hospital. "Not only is reproductive coercion associated with violence from male partners, but when women report experiencing both reproductive coercion and partner violence, the risk for unintended pregnancy increases significantly."
Conducted between August 2008 and March 2009 at five reproductive health clinics in Northern California, the study involved approximately 1,300 English- and Spanish-speaking 16- to 29-year-old women who agreed to respond to a computerized survey about their experiences with relationships and pregnancy.
Study participants were asked questions about birth-control sabotage, pregnancy coercion and intimate partner violence to assess their experience of pregnancy coercion and birth control sabotage. Questions included:
"Has someone you were dating or going out with ever told you not to use any birth control" or "??¦ said he would leave you if you would not get pregnant?"
"Has someone you were dating or going out with ever taken off the condom while you were having sex so that you would get pregnant?"
Approximately one in five young women said they experienced pregnancy coercion and 15 percent said they experienced birth control sabotage. Over half the respondents - 53 percent - said they had experienced physical or sexual violence from an intimate partner. More than a third of the women who reported partner violence - 35 percent - also reported either pregnancy coercion or birth control sabotage.
"We have known about the association between partner violence and unintended pregnancy for many years," said Jay Silverman, the study's senior author and an associate professor of society, human development and health in the Harvard School of Public Health. "What this study shows is that reproductive coercion likely explains why unintended pregnancies are far more common among abused women and teens."
The study authors said the research underscores the importance of educating women seeking care about reproductive coercion, and ensuring that women who are seeking reproductive health services are offered counseling on ways to prevent pregnancy that are less vulnerable to partner interference, as well as connected to domestic violence-related services. The study also highlights the importance of working with young men to prevent both violence against female partners and coercion around pregnancy.
"This study confirms that women experiencing partner violence are more likely to have greater need for sexual and reproductive health services," Miller said. "Thus, clinical settings that offer reproductive health services likely offer the greatest opportunity to identify women experiencing partner violence and to ensure that women receive the counseling and support they may need." Comprehensive assessment in clinical settings for pregnancy coercion, birth control sabotage and intimate partner violence should be considered a priority in the context of family planning services. Moreover, public health efforts to reduce unintended pregnancy should ensure that discussions of reproductive coercion are included in pregnancy prevention programs, she said.
Other study authors include Michele Decker and Heather McCauley of the Harvard School of Public Health, Daniel Tancredi of UC Davis, Rebecca Levenson of the Family Violence Prevention Fund of San Francisco, and Jeffrey Waldman and Phyllis Schoenwald of the Planned Parenthood Shasta Diablo Affiliate.
The study was funded by the National Institute of Child Health and Human Development as well as by a UC Davis Health System Research Award and a Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Award to Miller.
Source:
Phyllis Brown
University of California - Davis - Health System
четверг, 1 марта 2012 г.
Women With Polycystic Ovary Syndrome May Be More Vulnerable To BPA
A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), found higher Bisphenol A (BPA) levels in women with polycystic ovary syndrome (PCOS) compared to controls. Furthermore, researchers found a statistically significant positive association between male sex hormones and BPA in these women suggesting a potential role of BPA in ovarian dysfunction.
BPA is a very common industrial compound used in food and drink packaging, plastic consumer products and dental materials. PCOS is the most common endocrine disorder of women of reproductive age and is characterized by excessive secretion of androgens which are masculinization-promoting hormones. The syndrome raises the risk of obesity, type 2 diabetes, infertility and heart disease.
"Our research shows that BPA may be more harmful to women with hormonal and fertility imbalances like those found in PCOS," said Evanthia Diamanti-Kandarakis, MD, PhD, study co-author and professor at the University of Athens Medical School in Greece. "These women should be alert to the potential risks and take care of themselves by avoiding excessive every-day consumption of food or drink from plastic containers."
In this study, researchers divided 71 women with PCOS and 100 healthy female control subjects into subgroups matched by age and body composition. Blood levels of BPA were nearly 60 percent higher in lean women with PCOS and more than 30 percent higher in obese women with the syndrome when compared to controls. Additionally, as BPA levels increased, so did concentrations of the male sex hormone testosterone and androstenedione, a steroid hormone that converts to testosterone.
"Excessive secretion of androgens, as seen in PCOS, interfere with BPA detoxification by the liver, leading to accumulation of blood levels of BPA," said Diamanti-Kandarakis. "BPA also affects androgen metabolism, creating a vicious circle between androgens and BPA."
Other researchers working on the study include: Eleni Kandaraki of Huddersfield Royal Infirmary Hospital in West Yorkshire, United Kingdom; Antonis Chatzigeorgiou, Sarantis Livadas, Eleni Palioura, Frangiscos Economou, Michael Koutsilieris and Sotiria Palimeri of National and Kapodistrian University of Athens in Greece; and Dimitrios Panidis of Aristotle University of Thessaloniki in Greece.
The article, "Endocrine disruptors and polycystic ovary syndrome (PCOS): Elevated serum levels of Bisphenol A in women with PCOS," appears in the March 2011 issue of JCEM.
Source:
Endocrine Society
BPA is a very common industrial compound used in food and drink packaging, plastic consumer products and dental materials. PCOS is the most common endocrine disorder of women of reproductive age and is characterized by excessive secretion of androgens which are masculinization-promoting hormones. The syndrome raises the risk of obesity, type 2 diabetes, infertility and heart disease.
"Our research shows that BPA may be more harmful to women with hormonal and fertility imbalances like those found in PCOS," said Evanthia Diamanti-Kandarakis, MD, PhD, study co-author and professor at the University of Athens Medical School in Greece. "These women should be alert to the potential risks and take care of themselves by avoiding excessive every-day consumption of food or drink from plastic containers."
In this study, researchers divided 71 women with PCOS and 100 healthy female control subjects into subgroups matched by age and body composition. Blood levels of BPA were nearly 60 percent higher in lean women with PCOS and more than 30 percent higher in obese women with the syndrome when compared to controls. Additionally, as BPA levels increased, so did concentrations of the male sex hormone testosterone and androstenedione, a steroid hormone that converts to testosterone.
"Excessive secretion of androgens, as seen in PCOS, interfere with BPA detoxification by the liver, leading to accumulation of blood levels of BPA," said Diamanti-Kandarakis. "BPA also affects androgen metabolism, creating a vicious circle between androgens and BPA."
Other researchers working on the study include: Eleni Kandaraki of Huddersfield Royal Infirmary Hospital in West Yorkshire, United Kingdom; Antonis Chatzigeorgiou, Sarantis Livadas, Eleni Palioura, Frangiscos Economou, Michael Koutsilieris and Sotiria Palimeri of National and Kapodistrian University of Athens in Greece; and Dimitrios Panidis of Aristotle University of Thessaloniki in Greece.
The article, "Endocrine disruptors and polycystic ovary syndrome (PCOS): Elevated serum levels of Bisphenol A in women with PCOS," appears in the March 2011 issue of JCEM.
Source:
Endocrine Society
четверг, 23 февраля 2012 г.
Highest Risk Factor For Colorectal Cancer Among Women Is Obesity
Research presented at the 72nd Annual Scientific Meeting of the American College of Gastroenterology found that obesity, among other important risk factors, was the strongest risk factor for colorectal cancer in women.
Joseph C. Anderson, MD of Stony Brook University in New York (and the University of Connecticut) and his colleagues examined data from 1,252 women who underwent colonoscopy. They classified patients according to their age, smoking history, family history of colorectal cancer, and body mass index (BMI). Obesity was defined as a BMI of 30 or higher. For smoking, patients were divided into three groups: heavy exposure, low exposure, and no exposure. Patients who were in the heavy exposure group included women who had smoked more than 10 "pack years" and who were currently smoking or had quit in the past 10 years.
Although smoking posed a significant increased risk for colorectal neoplasia, researchers found that for women, obesity was the highest attributable risk factor for developing the disease. BMI accounted for one-fifth of all significant polyps detected during colonoscopy. Of those patients who had colorectal neoplasia, 20 percent were obese and 14 percent were smokers.
"Given the increasing number of obese patients in the U.S., identifying them as high risk may have important screening implications," said Dr. Anderson. "While obesity is positively associated with an increased risk of colorectal cancer, patients who lower their BMI could potentially reduce their risk of developing the disease in the future."
About Body Mass Index (BMI)
Body mass index, or BMI, is a measurement that determines the healthiness of a person's weight. The formula is related to the amount of fat a person carries and is calculated using the person's height and weight. A healthy BMI is between 18.5 and 24.9. People are considered underweight if their BMI is less than 18.5, overweight if their BMI is between 25 and 29.9, and obese if their BMI is 30 or higher.
About the American College of Gastroenterology
Founded in 1932, the American College of Gastroenterology (ACG) is an organization with an international membership of more than 10,000 individuals from 80 countries. The College is committed to serving the clinically oriented digestive disease specialist through its emphasis on scholarly practice, teaching and research. The mission of the College is to serve the evolving needs of physicians in the delivery of high quality, scientifically sound, humanistic, ethical, and cost-effective health care to gastroenterology patients.
The ACG is committed to providing accurate, unbiased and up-to-date health information. Visit the ACG Web site American College of Gastroenterology
to access educational resources for patients and their families spanning the broad range of digestive diseases and conditions -- both common and not-so-common. Organized by disease, state and organ system, these educational materials, developed by ACG physician experts, are offered for the information and benefit of patients and the public.
Source: Rosanne Riesenman
American College of Gastroenterology
Joseph C. Anderson, MD of Stony Brook University in New York (and the University of Connecticut) and his colleagues examined data from 1,252 women who underwent colonoscopy. They classified patients according to their age, smoking history, family history of colorectal cancer, and body mass index (BMI). Obesity was defined as a BMI of 30 or higher. For smoking, patients were divided into three groups: heavy exposure, low exposure, and no exposure. Patients who were in the heavy exposure group included women who had smoked more than 10 "pack years" and who were currently smoking or had quit in the past 10 years.
Although smoking posed a significant increased risk for colorectal neoplasia, researchers found that for women, obesity was the highest attributable risk factor for developing the disease. BMI accounted for one-fifth of all significant polyps detected during colonoscopy. Of those patients who had colorectal neoplasia, 20 percent were obese and 14 percent were smokers.
"Given the increasing number of obese patients in the U.S., identifying them as high risk may have important screening implications," said Dr. Anderson. "While obesity is positively associated with an increased risk of colorectal cancer, patients who lower their BMI could potentially reduce their risk of developing the disease in the future."
About Body Mass Index (BMI)
Body mass index, or BMI, is a measurement that determines the healthiness of a person's weight. The formula is related to the amount of fat a person carries and is calculated using the person's height and weight. A healthy BMI is between 18.5 and 24.9. People are considered underweight if their BMI is less than 18.5, overweight if their BMI is between 25 and 29.9, and obese if their BMI is 30 or higher.
About the American College of Gastroenterology
Founded in 1932, the American College of Gastroenterology (ACG) is an organization with an international membership of more than 10,000 individuals from 80 countries. The College is committed to serving the clinically oriented digestive disease specialist through its emphasis on scholarly practice, teaching and research. The mission of the College is to serve the evolving needs of physicians in the delivery of high quality, scientifically sound, humanistic, ethical, and cost-effective health care to gastroenterology patients.
The ACG is committed to providing accurate, unbiased and up-to-date health information. Visit the ACG Web site American College of Gastroenterology
to access educational resources for patients and their families spanning the broad range of digestive diseases and conditions -- both common and not-so-common. Organized by disease, state and organ system, these educational materials, developed by ACG physician experts, are offered for the information and benefit of patients and the public.
Source: Rosanne Riesenman
American College of Gastroenterology
четверг, 16 февраля 2012 г.
Mammography: Is It Right For Me? New Book Shines Light On Mammography Controversy
The subject of changing public advice over the years, mammography and the controversy over its use continue to cause confusion in the minds of many women. A new book for lay readers entitled "Understanding the Mammography Controversy: Science, Politics, and Breast Cancer Screening" (Praeger Press), by women's health expert Dr. Madelon L. Finkel of Weill Medical College of Cornell University, provides a comprehensive guide to mammography, the mammography controversy and breast health.
The book directly addresses the still-controversial issues, such as deciding when is the "right" time to have a mammogram, what is the "right" age for mammography (the body of evidence indicates a benefit for women aged 50 to 69) and whether mammography is useful at all (it is). While not perfect, mammography is the only population-based breast cancer screening method that has been shown to actually save lives.
"It's no wonder women are confused about mammography. Sensational media stories tout the latest scientific studies, often contradicting previous findings. Above all, women need to separate the facts from the myths in order to make informed decisions about their breast health," says Dr. Finkel, professor of clinical public health and director of the Office of Global Health Education at Weill Cornell Medical College.
This book includes a timeline that details the disagreement within the scientific community and changing public advice on mammography over the years.
"The mammography debate is still not yet settled. While the latest research shows that mammography can save lives, there is still no overall consensus on what age mammogram screening should be recommended, and even whether the benefits of mammogram screening outweigh the risks in the first place," says Dr. Finkel." Each woman must consider her personal risk factors, and in consultation with her doctor, decide when and how frequently mammography should be scheduled."
The book offers readers practical information, including how to give a breast self-exam, how to communicate with one's doctor, a list of support groups and organizations for breast cancer patients, and resources for clinical trials.
"Most women will not develop breast cancer in their lifetime, and for those who do, it's no longer a death sentence. Thanks to public awareness, screening, research and new treatment options, it has become a treatable, chronic illness," says Dr. Finkel.
"Understanding the Mammography Controversy: Science, Politics, and Breast Cancer Screening" received the highest rating from BookList. The book is dedicated to the author's mother, who died of breast cancer.
Dr. Madelon Finkel
Dr. Madelon Finkel has been involved in epidemiologic research and health-care policy studies for more than two decades. Her research has been focused on such women's health issues as teenage sexual behavior and hormone replacement therapy.
Dr. Finkel received an M.P.A. and Ph.D. in epidemiology and health services research from NYU. In addition to her titles at Weill Cornell Medical College, Dr. Finkel also holds the rank of professor of research in medicine at SUNY Stony Brook, and was a visiting professor at the School of Public Health, University of Sydney (Australia) in 2004. She is a member of the American College of Epidemiology, an advisor to the American Council on Science and Health, and a charter member of the Academy of Benefit Authors of the International Foundation of Employee Benefit Plans. Dr. Finkel was awarded the highest teaching honor at Weill Cornell, the Excellence in Teaching Award, in 2000 and 2005.
The Joan and Sanford I. Weill Medical College
The Joan and Sanford I. Weill Medical College -- located in New York City -- is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine. The Medical College, which is a principal academic affiliate of NewYork-Presbyterian Hospital, offers an innovative curriculum that integrates the teaching of basic and clinical sciences, problem-based learning, office-based preceptorships, and primary care and doctoring courses. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research in such areas as stem cells, genetics and gene therapy, geriatrics, neuroscience, structural biology, cardiovascular biology, AIDS, obesity, cancer and psychiatry -- and continue to delve ever-deeper into the molecular basis of disease in an effort to unlock the mysteries behind the human body and the malfunctions that result in serious medical disorders. Weill Cornell Medical College is the birthplace of many medical advances -- from the development of the Pap test for cervical cancer to the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., and most recently, the world's first clinical trial for gene therapy for Parkinson's disease. Weill Cornell's Physician Organization includes 650 clinical faculty who provide the highest quality of care to patients.
Joan and Sanford I. Weill Medical College of Cornell University
nyp
The book directly addresses the still-controversial issues, such as deciding when is the "right" time to have a mammogram, what is the "right" age for mammography (the body of evidence indicates a benefit for women aged 50 to 69) and whether mammography is useful at all (it is). While not perfect, mammography is the only population-based breast cancer screening method that has been shown to actually save lives.
"It's no wonder women are confused about mammography. Sensational media stories tout the latest scientific studies, often contradicting previous findings. Above all, women need to separate the facts from the myths in order to make informed decisions about their breast health," says Dr. Finkel, professor of clinical public health and director of the Office of Global Health Education at Weill Cornell Medical College.
This book includes a timeline that details the disagreement within the scientific community and changing public advice on mammography over the years.
"The mammography debate is still not yet settled. While the latest research shows that mammography can save lives, there is still no overall consensus on what age mammogram screening should be recommended, and even whether the benefits of mammogram screening outweigh the risks in the first place," says Dr. Finkel." Each woman must consider her personal risk factors, and in consultation with her doctor, decide when and how frequently mammography should be scheduled."
The book offers readers practical information, including how to give a breast self-exam, how to communicate with one's doctor, a list of support groups and organizations for breast cancer patients, and resources for clinical trials.
"Most women will not develop breast cancer in their lifetime, and for those who do, it's no longer a death sentence. Thanks to public awareness, screening, research and new treatment options, it has become a treatable, chronic illness," says Dr. Finkel.
"Understanding the Mammography Controversy: Science, Politics, and Breast Cancer Screening" received the highest rating from BookList. The book is dedicated to the author's mother, who died of breast cancer.
Dr. Madelon Finkel
Dr. Madelon Finkel has been involved in epidemiologic research and health-care policy studies for more than two decades. Her research has been focused on such women's health issues as teenage sexual behavior and hormone replacement therapy.
Dr. Finkel received an M.P.A. and Ph.D. in epidemiology and health services research from NYU. In addition to her titles at Weill Cornell Medical College, Dr. Finkel also holds the rank of professor of research in medicine at SUNY Stony Brook, and was a visiting professor at the School of Public Health, University of Sydney (Australia) in 2004. She is a member of the American College of Epidemiology, an advisor to the American Council on Science and Health, and a charter member of the Academy of Benefit Authors of the International Foundation of Employee Benefit Plans. Dr. Finkel was awarded the highest teaching honor at Weill Cornell, the Excellence in Teaching Award, in 2000 and 2005.
The Joan and Sanford I. Weill Medical College
The Joan and Sanford I. Weill Medical College -- located in New York City -- is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine. The Medical College, which is a principal academic affiliate of NewYork-Presbyterian Hospital, offers an innovative curriculum that integrates the teaching of basic and clinical sciences, problem-based learning, office-based preceptorships, and primary care and doctoring courses. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research in such areas as stem cells, genetics and gene therapy, geriatrics, neuroscience, structural biology, cardiovascular biology, AIDS, obesity, cancer and psychiatry -- and continue to delve ever-deeper into the molecular basis of disease in an effort to unlock the mysteries behind the human body and the malfunctions that result in serious medical disorders. Weill Cornell Medical College is the birthplace of many medical advances -- from the development of the Pap test for cervical cancer to the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., and most recently, the world's first clinical trial for gene therapy for Parkinson's disease. Weill Cornell's Physician Organization includes 650 clinical faculty who provide the highest quality of care to patients.
Joan and Sanford I. Weill Medical College of Cornell University
nyp
Подписаться на:
Сообщения (Atom)